Benefits Of A Patient-Centric Design In Oncology Trials

Study stress associated with patient recruitment and retention worsens as oncology trials become more competitive. From enrollment through retention, each patient involved in a clinical trial is critical when compiling complete data sets. And while in-home healthcare has been in place for cancer patients for years, the adoption of decentralized trial visits to provide in-home clinical care during a trial has slowly gained more traction in the life sciences industry.

We all know that it can be exhausting traveling to a site for every trial visit. The additional burden of disease making a patient feel unwell only exacerbates this, further emphasizing the need to provide oncology patients with the right level of care.

Examine how allowing patient flexibility during decentralized clinical trial visits can improve an oncology study's results while meeting legal, compliance, and quality regulations.